Booster doses of the original monovalent COVID-19 vaccine are associated with lower incidence of symptoms in health care personnel 6 weeks postinfection.

An estimated 15.5 million U.S adults had a current diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2023.

People with a high number of antiseizure medications seem to be at risk for accelerated neuroaxonal loss. HealthDay News — In people with epilepsy, progression of retinal neuroaxonal loss is ...

Youth antidepressant warnings had a detrimental unintended effect: significant reductions in mental health care.

The PROVIDE model of video consultation leads to a decrease in depressive and anxiety symptoms among primary care patients.

HealthDay News — Socioeconomic factors are linked to an increased risk for age-related macular degeneration (AMD), according to a study published online July 1 in Health Data Science.

Air pollution exposure is associated with an increased risk of developing Parkinson disease (PD) and dyskinesia, according to study results published in JAMA Network Open.

Odds of postpartum depression are reduced by 45 percent in individuals who engaged in postpartum exercise, according to a study.

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

About one in five adults experienced any symptoms of anxiety and symptoms of depression during 2022, according to a study.

Lifestyle/Antisocial traits, but not Interpersonal/Affective factors, were associated with executive dysfunction in general psychopathy.

The American Academy of Sleep Medicine updated its guidelines on the treatment of restless leg syndrome and periodic limb ...